Skip to main content
Top
Published in: Journal of Inherited Metabolic Disease 3/2015

01-05-2015 | Glycogenoses

Exercise in muscle glycogen storage diseases

Authors: Nicolai Preisler, Ronald G Haller, John Vissing

Published in: Journal of Inherited Metabolic Disease | Issue 3/2015

Login to get access

Abstract

Glycogen storage diseases (GSD) are inborn errors of glycogen or glucose metabolism. In the GSDs that affect muscle, the consequence of a block in skeletal muscle glycogen breakdown or glucose use, is an impairment of muscular performance and exercise intolerance, owing to 1) an increase in glycogen storage that disrupts contractile function and/or 2) a reduced substrate turnover below the block, which inhibits skeletal muscle ATP production. Immobility is associated with metabolic alterations in muscle leading to an increased dependence on glycogen use and a reduced capacity for fatty acid oxidation. Such changes may be detrimental for persons with GSD from a metabolic perspective. However, exercise may alter skeletal muscle substrate metabolism in ways that are beneficial for patients with GSD, such as improving exercise tolerance and increasing fatty acid oxidation. In addition, a regular exercise program has the potential to improve general health and fitness and improve quality of life, if executed properly. In this review, we describe skeletal muscle substrate use during exercise in GSDs, and how blocks in metabolic pathways affect exercise tolerance in GSDs. We review the studies that have examined the effect of regular exercise training in different types of GSD. Finally, we consider how oral substrate supplementation can improve exercise tolerance and we discuss the precautions that apply to persons with GSD that engage in exercise.
Literature
go back to reference Ainsworth BE, Haskell WL, Herrmann SD et al (2011) 2011 compendium of physical activities: a second update of codes and MET values. Med Sci Sports Exerc 43:1575–1581CrossRefPubMed Ainsworth BE, Haskell WL, Herrmann SD et al (2011) 2011 compendium of physical activities: a second update of codes and MET values. Med Sci Sports Exerc 43:1575–1581CrossRefPubMed
go back to reference Andersen ST, Haller RG, Vissing J (2008) Effect of oral sucrose shortly before exercise on work capacity in McArdle disease. Arch Neurol 65:786–789PubMed Andersen ST, Haller RG, Vissing J (2008) Effect of oral sucrose shortly before exercise on work capacity in McArdle disease. Arch Neurol 65:786–789PubMed
go back to reference Baethmann M, Straub V, & Reuser AJ (2008) Pompe disease, 1st edn., pp 8-104. UNI-MED , Bremen Baethmann M, Straub V, & Reuser AJ (2008) Pompe disease, 1st edn., pp 8-104. UNI-MED , Bremen
go back to reference Bassett DR Jr, Howley ET (2000) Limiting factors for maximum oxygen uptake and determinants of endurance performance. Med Sci Sports Exerc 32:70–84CrossRefPubMed Bassett DR Jr, Howley ET (2000) Limiting factors for maximum oxygen uptake and determinants of endurance performance. Med Sci Sports Exerc 32:70–84CrossRefPubMed
go back to reference Bembi B, Cerini E, Danesino C et al (2008) Diagnosis of glycogenosis type II. Neurology 71:S4–S11CrossRefPubMed Bembi B, Cerini E, Danesino C et al (2008) Diagnosis of glycogenosis type II. Neurology 71:S4–S11CrossRefPubMed
go back to reference Blair SN, Kohl HW III, Barlow CE, Paffenbarger RS Jr, Gibbons LW, Macera CA (1995) Changes in physical fitness and all-cause mortality. a prospective study of healthy and unhealthy men. JAMA 273:1093–1098CrossRefPubMed Blair SN, Kohl HW III, Barlow CE, Paffenbarger RS Jr, Gibbons LW, Macera CA (1995) Changes in physical fitness and all-cause mortality. a prospective study of healthy and unhealthy men. JAMA 273:1093–1098CrossRefPubMed
go back to reference Chasiotis D, Sahlin K, Hultman E (1982) Regulation of glycogenolysis in human muscle at rest and during exercise. J Appl Physiol 53:708–715CrossRefPubMed Chasiotis D, Sahlin K, Hultman E (1982) Regulation of glycogenolysis in human muscle at rest and during exercise. J Appl Physiol 53:708–715CrossRefPubMed
go back to reference Coleman RA, Stajich JM, Pact VW, Pericak-Vance MA (1986) The ischemic exercise test in normal adults and in patients with weakness and cramps. Muscle Nerve 9:216–221CrossRefPubMed Coleman RA, Stajich JM, Pact VW, Pericak-Vance MA (1986) The ischemic exercise test in normal adults and in patients with weakness and cramps. Muscle Nerve 9:216–221CrossRefPubMed
go back to reference Coleman RA, Winter HS, Wolf B, Gilchrist JM, Chen YT (1992) Glycogen storage disease type III (glycogen debranching enzyme deficiency): correlation of biochemical defects with myopathy and cardiomyopathy. Ann Intern Med 116:896–900CrossRefPubMed Coleman RA, Winter HS, Wolf B, Gilchrist JM, Chen YT (1992) Glycogen storage disease type III (glycogen debranching enzyme deficiency): correlation of biochemical defects with myopathy and cardiomyopathy. Ann Intern Med 116:896–900CrossRefPubMed
go back to reference Cory JG (2006) Purine and pyrimidine nucleotide metabolism. In: Devlin TM (ed) Textbook of biochemistry: with clinical correlations. Wiley-Liss, Hoboken, pp 789–822 Cory JG (2006) Purine and pyrimidine nucleotide metabolism. In: Devlin TM (ed) Textbook of biochemistry: with clinical correlations. Wiley-Liss, Hoboken, pp 789–822
go back to reference DiMauro S, Hartwig GB, Hays A et al (1979) Debrancher deficiency: neuromuscular disorder in 5 adults. Ann Neurol 5:422–436CrossRefPubMed DiMauro S, Hartwig GB, Hays A et al (1979) Debrancher deficiency: neuromuscular disorder in 5 adults. Ann Neurol 5:422–436CrossRefPubMed
go back to reference DiMauro S, Miranda AF, Khan S, Gitlin K, Friedman R (1981) Human muscle phosphoglycerate mutase deficiency: newly discovered metabolic myopathy. Science 212:1277–1279CrossRefPubMed DiMauro S, Miranda AF, Khan S, Gitlin K, Friedman R (1981) Human muscle phosphoglycerate mutase deficiency: newly discovered metabolic myopathy. Science 212:1277–1279CrossRefPubMed
go back to reference DiMauro S, Hays AP, Tsujino S (2004) Metabolic disorders affecting muscle. In: Engel AG, Franzini-Armstrong C (eds) Myology. McGraw-Hill, New York, pp 1535–1558 DiMauro S, Hays AP, Tsujino S (2004) Metabolic disorders affecting muscle. In: Engel AG, Franzini-Armstrong C (eds) Myology. McGraw-Hill, New York, pp 1535–1558
go back to reference Ding JH, De BT, De BT, Brown BI, Coleman RA, Chen YT (1990) Immunoblot analyses of glycogen debranching enzyme in different subtypes of glycogen storage disease type III. J Pediatr 116:95–100CrossRefPubMed Ding JH, De BT, De BT, Brown BI, Coleman RA, Chen YT (1990) Immunoblot analyses of glycogen debranching enzyme in different subtypes of glycogen storage disease type III. J Pediatr 116:95–100CrossRefPubMed
go back to reference Echaniz-Laguna A, Akman HO, Mohr M et al (2010) Muscle phosphorylase b kinase deficiency revisited. Neuromuscul Disord 20:125–127CrossRefPubMed Echaniz-Laguna A, Akman HO, Mohr M et al (2010) Muscle phosphorylase b kinase deficiency revisited. Neuromuscul Disord 20:125–127CrossRefPubMed
go back to reference Haller RG, Lewis SF (1991) Glucose-induced exertional fatigue in muscle phosphofructokinase deficiency. N Engl J Med 324:364–369CrossRefPubMed Haller RG, Lewis SF (1991) Glucose-induced exertional fatigue in muscle phosphofructokinase deficiency. N Engl J Med 324:364–369CrossRefPubMed
go back to reference Haller RG, Vissing J (2002) Spontaneous “second wind” and glucose-induced second “second wind” in McArdle disease: oxidative mechanisms. Arch Neurol 59:1395–1402PubMed Haller RG, Vissing J (2002) Spontaneous “second wind” and glucose-induced second “second wind” in McArdle disease: oxidative mechanisms. Arch Neurol 59:1395–1402PubMed
go back to reference Haller RG, Vissing J (2004a) Functional evaluation of metabolic myopathies. In: Engel AG, Franzini-Armstrong C (eds) Myology. McGraw-Hill, New York, pp 665–679 Haller RG, Vissing J (2004a) Functional evaluation of metabolic myopathies. In: Engel AG, Franzini-Armstrong C (eds) Myology. McGraw-Hill, New York, pp 665–679
go back to reference Haller RG, Vissing J (2004b) No spontaneous second wind in muscle phosphofructokinase deficiency. Neurology 62:82–86CrossRefPubMed Haller RG, Vissing J (2004b) No spontaneous second wind in muscle phosphofructokinase deficiency. Neurology 62:82–86CrossRefPubMed
go back to reference Haller RG, Lewis SF, Cook JD, Blomqvist CG (1985) Myophosphorylase deficiency impairs muscle oxidative metabolism. Ann Neurol 17:196–199CrossRefPubMed Haller RG, Lewis SF, Cook JD, Blomqvist CG (1985) Myophosphorylase deficiency impairs muscle oxidative metabolism. Ann Neurol 17:196–199CrossRefPubMed
go back to reference Haller RG, Wyrick P, Taivassalo T, Vissing J (2006) Aerobic conditioning: an effective therapy in McArdle’s disease. Ann Neurol 59:922–928CrossRefPubMed Haller RG, Wyrick P, Taivassalo T, Vissing J (2006) Aerobic conditioning: an effective therapy in McArdle’s disease. Ann Neurol 59:922–928CrossRefPubMed
go back to reference Harris RA (2006) Carbohydrate metabolism I: major metabolic pathways and their control. In: Devlin TM (ed) Textbook of biochemistry with clinical correlations. Wiley-Liss, New York, pp 581–635 Harris RA (2006) Carbohydrate metabolism I: major metabolic pathways and their control. In: Devlin TM (ed) Textbook of biochemistry with clinical correlations. Wiley-Liss, New York, pp 581–635
go back to reference Harris RA, Crabb DW (2006) Metabolic interrelationships. In: Devlin TM (ed) Textbook of biochemistry: with clinical correlations. Wiley-Liss, Hoboken, pp 849–890 Harris RA, Crabb DW (2006) Metabolic interrelationships. In: Devlin TM (ed) Textbook of biochemistry: with clinical correlations. Wiley-Liss, Hoboken, pp 849–890
go back to reference Hermansen L, Hultman E, Saltin B (1967) Muscle glycogen during prolonged severe exercise. Acta Physiol Scand 71:129–139CrossRefPubMed Hermansen L, Hultman E, Saltin B (1967) Muscle glycogen during prolonged severe exercise. Acta Physiol Scand 71:129–139CrossRefPubMed
go back to reference Hers HG (1963) alpha-Glucosidase deficiency in generalized glycogenstorage disease (Pompe’s disease). Biochem J 86:11–16PubMedCentralPubMed Hers HG (1963) alpha-Glucosidase deficiency in generalized glycogenstorage disease (Pompe’s disease). Biochem J 86:11–16PubMedCentralPubMed
go back to reference Hogrel JY, Laforet P, Ben YR, Chevrot M, Eymard B, Lombes A (2001) A non-ischemic forearm exercise test for the screening of patients with exercise intolerance. Neurology 56:1733–1738CrossRefPubMed Hogrel JY, Laforet P, Ben YR, Chevrot M, Eymard B, Lombes A (2001) A non-ischemic forearm exercise test for the screening of patients with exercise intolerance. Neurology 56:1733–1738CrossRefPubMed
go back to reference Kazemi-Esfarjani P, Skomorowska E, Jensen TD, Haller RG, Vissing J (2002) A nonischemic forearm exercise test for McArdle disease. Ann Neurol 52:153–159CrossRefPubMed Kazemi-Esfarjani P, Skomorowska E, Jensen TD, Haller RG, Vissing J (2002) A nonischemic forearm exercise test for McArdle disease. Ann Neurol 52:153–159CrossRefPubMed
go back to reference Kishnani PS, Austin SL, Arn P et al (2010) Glycogen storage disease type III diagnosis and management guidelines. Genet Med 12:446–463CrossRefPubMed Kishnani PS, Austin SL, Arn P et al (2010) Glycogen storage disease type III diagnosis and management guidelines. Genet Med 12:446–463CrossRefPubMed
go back to reference Laforet P, Weinstein DA, Smit PA (2012) The glycogen storage diseases and related disorders. In: Saudubray JM, van den Berghe G, Walter JH (eds) Inborn metabolic diseases. Springer, Berlin Heidelberg, pp 115–139CrossRef Laforet P, Weinstein DA, Smit PA (2012) The glycogen storage diseases and related disorders. In: Saudubray JM, van den Berghe G, Walter JH (eds) Inborn metabolic diseases. Springer, Berlin Heidelberg, pp 115–139CrossRef
go back to reference Lewis SF, Vora S, Haller RG (1991) Abnormal oxidative metabolism and O2 transport in muscle phosphofructokinase deficiency. J Appl Physiol 70:391–398PubMed Lewis SF, Vora S, Haller RG (1991) Abnormal oxidative metabolism and O2 transport in muscle phosphofructokinase deficiency. J Appl Physiol 70:391–398PubMed
go back to reference Lucia A, Nogales-Gadea G, Perez M, Martin MA, Andreu AL, Arenas J (2008) McArdle disease: what do neurologists need to know? Nat Clin Pract Neurol 4:568–577CrossRefPubMed Lucia A, Nogales-Gadea G, Perez M, Martin MA, Andreu AL, Arenas J (2008) McArdle disease: what do neurologists need to know? Nat Clin Pract Neurol 4:568–577CrossRefPubMed
go back to reference Lucia A, Ruiz JR, Santalla A et al (2012) Genotypic and phenotypic features of McArdle disease: insights from the Spanish national registry. J Neurol Neurosurg Psychiatry 83:322–328CrossRefPubMed Lucia A, Ruiz JR, Santalla A et al (2012) Genotypic and phenotypic features of McArdle disease: insights from the Spanish national registry. J Neurol Neurosurg Psychiatry 83:322–328CrossRefPubMed
go back to reference Mate-Munoz JL, Moran M, Perez M et al (2007) Favorable responses to acute and chronic exercise in McArdle patients. Clin J Sport Med 17:297–303CrossRefPubMed Mate-Munoz JL, Moran M, Perez M et al (2007) Favorable responses to acute and chronic exercise in McArdle patients. Clin J Sport Med 17:297–303CrossRefPubMed
go back to reference McAlpine PJ, Hopkinson DA, Harris H (1970) The relative activities attributable to the three phosphoglucomutase loci (PGM1, PGM2, PGM3) in human tissues. Ann Hum Genet 34:169–175CrossRefPubMed McAlpine PJ, Hopkinson DA, Harris H (1970) The relative activities attributable to the three phosphoglucomutase loci (PGM1, PGM2, PGM3) in human tissues. Ann Hum Genet 34:169–175CrossRefPubMed
go back to reference McArdle WD, Katch FI, Katch VL (2007a) Energy transfer in the body. In: McArdle WD, Katch FI, Katch VL (eds) Exercise physiology: energy, nutrition, & human performance. Lippincott Williams & Wilkins, Baltimore, pp 137–163 McArdle WD, Katch FI, Katch VL (2007a) Energy transfer in the body. In: McArdle WD, Katch FI, Katch VL (eds) Exercise physiology: energy, nutrition, & human performance. Lippincott Williams & Wilkins, Baltimore, pp 137–163
go back to reference McArdle WD, Katch FI, Katch VL (2007b) Individual differences and measurement of energy capacities. In: McArdle WD, Katch FI, Katch VL (eds) Exercise physiology: energy, nutrition & human performance. Lippincott Williams & Wilkins, Baltimore, pp 229–253 McArdle WD, Katch FI, Katch VL (2007b) Individual differences and measurement of energy capacities. In: McArdle WD, Katch FI, Katch VL (eds) Exercise physiology: energy, nutrition & human performance. Lippincott Williams & Wilkins, Baltimore, pp 229–253
go back to reference Moses SW, Gadoth N, Bashan N, Ben-David E, Slonim A, Wanderman KL (1986) Neuromuscular involvement in glycogen storage disease type III. Acta Paediatr Scand 75:289–296CrossRefPubMed Moses SW, Gadoth N, Bashan N, Ben-David E, Slonim A, Wanderman KL (1986) Neuromuscular involvement in glycogen storage disease type III. Acta Paediatr Scand 75:289–296CrossRefPubMed
go back to reference Nadaj-Pakleza AA, Vincitorio CM, Laforet P et al (2009) Permanent muscle weakness in McArdle disease. Muscle Nerve 40:350–357CrossRefPubMed Nadaj-Pakleza AA, Vincitorio CM, Laforet P et al (2009) Permanent muscle weakness in McArdle disease. Muscle Nerve 40:350–357CrossRefPubMed
go back to reference Naini A, Toscano A, Musumeci O, Vissing J, Akman HO, DiMauro S (2009) Muscle phosphoglycerate mutase deficiency revisited. Arch Neurol 66:394–398PubMed Naini A, Toscano A, Musumeci O, Vissing J, Akman HO, DiMauro S (2009) Muscle phosphoglycerate mutase deficiency revisited. Arch Neurol 66:394–398PubMed
go back to reference Nakajima H, Raben N, Hamaguchi T, Yamasaki T (2002) Phosphofructokinase deficiency; past, present and future. Curr Mol Med 2:197–212CrossRefPubMed Nakajima H, Raben N, Hamaguchi T, Yamasaki T (2002) Phosphofructokinase deficiency; past, present and future. Curr Mol Med 2:197–212CrossRefPubMed
go back to reference Nilsson MI, Samjoo IA, Hettinga BP et al (2012) Aerobic training as an adjunctive therapy to enzyme replacement in Pompe disease. Mol Genet Metab 107:469–479CrossRefPubMed Nilsson MI, Samjoo IA, Hettinga BP et al (2012) Aerobic training as an adjunctive therapy to enzyme replacement in Pompe disease. Mol Genet Metab 107:469–479CrossRefPubMed
go back to reference Oh SJ, Park KS, Ryan HF Jr, Danon MJ, Lu J, Naini AB, DiMauro S (2006) Exercise-induced cramp, myoglobinuria, and tubular aggregates in phosphoglycerate mutase deficiency. Muscle Nerve 34:572–576CrossRefPubMed Oh SJ, Park KS, Ryan HF Jr, Danon MJ, Lu J, Naini AB, DiMauro S (2006) Exercise-induced cramp, myoglobinuria, and tubular aggregates in phosphoglycerate mutase deficiency. Muscle Nerve 34:572–576CrossRefPubMed
go back to reference Ollivier K, Hogrel JY, Gomez-Merino D, Berkani M, Eymard B, Portero P (2005a) Effects of an endurance training on patients with McArdle’s disease. Sci Sports 20:21–26CrossRef Ollivier K, Hogrel JY, Gomez-Merino D, Berkani M, Eymard B, Portero P (2005a) Effects of an endurance training on patients with McArdle’s disease. Sci Sports 20:21–26CrossRef
go back to reference Ollivier K, Hogrel JY, Gomez-Merino D et al (2005b) Exercise tolerance and daily life in McArdle’s disease. Muscle Nerve 31:637–641CrossRefPubMed Ollivier K, Hogrel JY, Gomez-Merino D et al (2005b) Exercise tolerance and daily life in McArdle’s disease. Muscle Nerve 31:637–641CrossRefPubMed
go back to reference Ono A, Kuwajima M, Kono N et al (1995) Glucose infusion paradoxically accelerates degradation of adenine nucleotide in working muscle of patients with glycogen storage disease type VII. Neurology 45:161–164CrossRefPubMed Ono A, Kuwajima M, Kono N et al (1995) Glucose infusion paradoxically accelerates degradation of adenine nucleotide in working muscle of patients with glycogen storage disease type VII. Neurology 45:161–164CrossRefPubMed
go back to reference Orngreen MC, Schelhaas HJ, Jeppesen TD et al (2008) Is muscle glycogenolysis impaired in X-linked phosphorylase b kinase deficiency? Neurology 70:1876–1882CrossRefPubMed Orngreen MC, Schelhaas HJ, Jeppesen TD et al (2008) Is muscle glycogenolysis impaired in X-linked phosphorylase b kinase deficiency? Neurology 70:1876–1882CrossRefPubMed
go back to reference Orngreen MC, Jeppesen TD, Andersen ST et al (2009) Fat metabolism during exercise in patients with McArdle disease. Neurology 72:718–724CrossRefPubMed Orngreen MC, Jeppesen TD, Andersen ST et al (2009) Fat metabolism during exercise in patients with McArdle disease. Neurology 72:718–724CrossRefPubMed
go back to reference Pearson CM, Rimer DG, Mommaerts WF (1961) A metabolic myopathy due to absence of muscle phosphorylase. Am J Med 30:502–517CrossRefPubMed Pearson CM, Rimer DG, Mommaerts WF (1961) A metabolic myopathy due to absence of muscle phosphorylase. Am J Med 30:502–517CrossRefPubMed
go back to reference Pedersen BK, Saltin B (2006) Evidence for prescribing exercise as therapy in chronic disease. Scand J Med Sci Sports 16(1):3–63CrossRefPubMed Pedersen BK, Saltin B (2006) Evidence for prescribing exercise as therapy in chronic disease. Scand J Med Sci Sports 16(1):3–63CrossRefPubMed
go back to reference Perez B, Medrano C, Ecay MJ, Ruiz-Sala P, Martinez-Pardo M, Ugarte M, Perez-Cerda C (2013) A novel congenital disorder of glycosylation type without central nervous system involvement caused by mutations in the phosphoglucomutase 1 gene. J Inherit Metab Dis 36:535–542CrossRefPubMed Perez B, Medrano C, Ecay MJ, Ruiz-Sala P, Martinez-Pardo M, Ugarte M, Perez-Cerda C (2013) A novel congenital disorder of glycosylation type without central nervous system involvement caused by mutations in the phosphoglucomutase 1 gene. J Inherit Metab Dis 36:535–542CrossRefPubMed
go back to reference Peronnet F, Massicotte D (1991) Table of nonprotein respiratory quotient: an update. Can J Sport Sci 16:23–29PubMed Peronnet F, Massicotte D (1991) Table of nonprotein respiratory quotient: an update. Can J Sport Sci 16:23–29PubMed
go back to reference Preisler N, Laforet P, Madsen KL et al (2012a) Fat and carbohydrate metabolism during exercise in late-onset Pompe disease. Mol Genet Metab 107:462–468CrossRefPubMed Preisler N, Laforet P, Madsen KL et al (2012a) Fat and carbohydrate metabolism during exercise in late-onset Pompe disease. Mol Genet Metab 107:462–468CrossRefPubMed
go back to reference Preisler N, Orngreen MC, Echaniz-Laguna A et al (2012b) Muscle phosphorylase kinase deficiency: a neutral metabolic variant or a disease? Neurology 78:265–268CrossRefPubMed Preisler N, Orngreen MC, Echaniz-Laguna A et al (2012b) Muscle phosphorylase kinase deficiency: a neutral metabolic variant or a disease? Neurology 78:265–268CrossRefPubMed
go back to reference Preisler N, Laforet P, Echaniz-Laguna A (2013a) Fat and carbohydrate metabolism during exercise in phosphoglucomutase type 1 deficiency. J Clin Endocrinol Metab 98:E1235–E1240CrossRefPubMed Preisler N, Laforet P, Echaniz-Laguna A (2013a) Fat and carbohydrate metabolism during exercise in phosphoglucomutase type 1 deficiency. J Clin Endocrinol Metab 98:E1235–E1240CrossRefPubMed
go back to reference Preisler N, Pradel A, Husu E et al (2013b) Exercise intolerance in glycogen storage disease type III: weakness or energy deficiency? Mol Genet Metab 109:14–20CrossRefPubMed Preisler N, Pradel A, Husu E et al (2013b) Exercise intolerance in glycogen storage disease type III: weakness or energy deficiency? Mol Genet Metab 109:14–20CrossRefPubMed
go back to reference Quinlivan R, Vissing J, Hilton-Jones D, & Buckley J (2011) Physical training for McArdle disease. Cochrane Database Syst Rev CD007931 Quinlivan R, Vissing J, Hilton-Jones D, & Buckley J (2011) Physical training for McArdle disease. Cochrane Database Syst Rev CD007931
go back to reference Richter EA, Hargreaves M (2013) Exercise, GLUT4, and skeletal muscle glucose uptake. Physiol Rev 93:993–1017CrossRefPubMed Richter EA, Hargreaves M (2013) Exercise, GLUT4, and skeletal muscle glucose uptake. Physiol Rev 93:993–1017CrossRefPubMed
go back to reference Rodriguez NR, Di Marco NM, Langley S (2009) American college of sports medicine position stand. nutrition and athletic performance. Med Sci Sports Exerc 41:709–731CrossRefPubMed Rodriguez NR, Di Marco NM, Langley S (2009) American college of sports medicine position stand. nutrition and athletic performance. Med Sci Sports Exerc 41:709–731CrossRefPubMed
go back to reference Sacconi S, Wahbi K, Theodore G et al (2014) Atrio-ventricular block requiring pacemaker in patients with late onset Pompe disease. Neuromuscul Disord 24:648–650CrossRefPubMed Sacconi S, Wahbi K, Theodore G et al (2014) Atrio-ventricular block requiring pacemaker in patients with late onset Pompe disease. Neuromuscul Disord 24:648–650CrossRefPubMed
go back to reference Sakoda S, Shanske S, DiMauro S, Schon EA (1988) Isolation of a cDNA encoding the B isozyme of human phosphoglycerate mutase (PGAM) and characterization of the PGAM gene family. J Biol Chem 263:16899–16905PubMed Sakoda S, Shanske S, DiMauro S, Schon EA (1988) Isolation of a cDNA encoding the B isozyme of human phosphoglycerate mutase (PGAM) and characterization of the PGAM gene family. J Biol Chem 263:16899–16905PubMed
go back to reference Shanske S, Sakoda S, Hermodson MA, DiMauro S, Schon EA (1987) Isolation of a cDNA encoding the muscle-specific subunit of human phosphoglycerate mutase. J Biol Chem 262:14612–14617PubMed Shanske S, Sakoda S, Hermodson MA, DiMauro S, Schon EA (1987) Isolation of a cDNA encoding the muscle-specific subunit of human phosphoglycerate mutase. J Biol Chem 262:14612–14617PubMed
go back to reference Slonim AE, Bulone L, Goldberg T et al (2007) Modification of the natural history of adult-onset acid maltase deficiency by nutrition and exercise therapy. Muscle Nerve 35:70–77CrossRefPubMed Slonim AE, Bulone L, Goldberg T et al (2007) Modification of the natural history of adult-onset acid maltase deficiency by nutrition and exercise therapy. Muscle Nerve 35:70–77CrossRefPubMed
go back to reference Smith TE (2006) Molecular cell biology. In: Devlin TM (ed) Textbook of biochemistry: with clinical correlations. Wiley-Liss, Hoboken, pp 949–1011 Smith TE (2006) Molecular cell biology. In: Devlin TM (ed) Textbook of biochemistry: with clinical correlations. Wiley-Liss, Hoboken, pp 949–1011
go back to reference Stein TP, Wade CE (2005) Metabolic consequences of muscle disuse atrophy. J Nutr 135:1824S–1828SPubMed Stein TP, Wade CE (2005) Metabolic consequences of muscle disuse atrophy. J Nutr 135:1824S–1828SPubMed
go back to reference Stojkovic T, Vissing J, Petit F et al (2009) Muscle glycogenosis due to phosphoglucomutase 1 deficiency. N Engl J Med 361:425–427CrossRefPubMed Stojkovic T, Vissing J, Petit F et al (2009) Muscle glycogenosis due to phosphoglucomutase 1 deficiency. N Engl J Med 361:425–427CrossRefPubMed
go back to reference Straub V (2008) Diagnosis. In Pompe Disease pp. 47-58. UNI-MED Verlag AG, D-28323 Bremen Straub V (2008) Diagnosis. In Pompe Disease pp. 47-58. UNI-MED Verlag AG, D-28323 Bremen
go back to reference Strothotte S, Strigl-Pill N, Grunert B et al (2010) Enzyme replacement therapy with alglucosidase alfa in 44 patients with late-onset glycogen storage disease type 2: 12-month results of an observational clinical trial. J Neurol 257:91–97CrossRefPubMed Strothotte S, Strigl-Pill N, Grunert B et al (2010) Enzyme replacement therapy with alglucosidase alfa in 44 patients with late-onset glycogen storage disease type 2: 12-month results of an observational clinical trial. J Neurol 257:91–97CrossRefPubMed
go back to reference Terzis G, Dimopoulos F, Papadimas GK et al (2011) Effect of aerobic and resistance exercise training on late-onset Pompe disease patients receiving enzyme replacement therapy. Mol Genet Metab 104:279–283CrossRefPubMed Terzis G, Dimopoulos F, Papadimas GK et al (2011) Effect of aerobic and resistance exercise training on late-onset Pompe disease patients receiving enzyme replacement therapy. Mol Genet Metab 104:279–283CrossRefPubMed
go back to reference Terzis G, Krase A, Papadimas G, Papadopoulos C, Kavouras SA, Manta P (2012) Effects of exercise training during infusion on late-onset Pompe disease patients receiving enzyme replacement therapy. Mol Genet Metab 107:669–673CrossRefPubMed Terzis G, Krase A, Papadimas G, Papadopoulos C, Kavouras SA, Manta P (2012) Effects of exercise training during infusion on late-onset Pompe disease patients receiving enzyme replacement therapy. Mol Genet Metab 107:669–673CrossRefPubMed
go back to reference Thompson WR, Gordon NF, Pescatello LS (2010) Pre-exercise evaluations. In: Thompson WR, Gordon NF, Pescatello LS (eds) ACSM’s guidelines for exercise testing and prescription. Kluwer & Lippincott Williams & Wilkins, Baltimore, pp 42–59 Thompson WR, Gordon NF, Pescatello LS (2010) Pre-exercise evaluations. In: Thompson WR, Gordon NF, Pescatello LS (eds) ACSM’s guidelines for exercise testing and prescription. Kluwer & Lippincott Williams & Wilkins, Baltimore, pp 42–59
go back to reference van den Berg LE (2014). The musculoskeletal system in Pompe disease: pathology, consequences and treatment options. Dissertation, Erasmus Universiteit Rotterdam. van den Berg LE (2014). The musculoskeletal system in Pompe disease: pathology, consequences and treatment options. Dissertation, Erasmus Universiteit Rotterdam.
go back to reference van der Ploeg AT, Clemens PR, Corzo D et al (2010) A randomized study of alglucosidase alfa in late-onset Pompe’s disease. N Engl J Med 362:1396–1406CrossRefPubMed van der Ploeg AT, Clemens PR, Corzo D et al (2010) A randomized study of alglucosidase alfa in late-onset Pompe’s disease. N Engl J Med 362:1396–1406CrossRefPubMed
go back to reference van der Ploeg AT, Barohn R, Carlson L et al (2012) Open-label extension study following the late-onset treatment study (LOTS) of alglucosidase alfa. Mol Genet Metab 107:456–461CrossRefPubMed van der Ploeg AT, Barohn R, Carlson L et al (2012) Open-label extension study following the late-onset treatment study (LOTS) of alglucosidase alfa. Mol Genet Metab 107:456–461CrossRefPubMed
go back to reference van Loon LJ, Greenhaff PL, Constantin-Teodosiu D, Saris WH, Wagenmakers AJ (2001) The effects of increasing exercise intensity on muscle fuel utilisation in humans. J Physiol 536:295–304CrossRefPubMedCentralPubMed van Loon LJ, Greenhaff PL, Constantin-Teodosiu D, Saris WH, Wagenmakers AJ (2001) The effects of increasing exercise intensity on muscle fuel utilisation in humans. J Physiol 536:295–304CrossRefPubMedCentralPubMed
go back to reference Vissing J, Haller RG (2003) The effect of oral sucrose on exercise tolerance in patients with McArdle’s disease. N Engl J Med 349:2503–2509CrossRefPubMed Vissing J, Haller RG (2003) The effect of oral sucrose on exercise tolerance in patients with McArdle’s disease. N Engl J Med 349:2503–2509CrossRefPubMed
go back to reference Vissing J, Orngreen M (2014) Metabolic myopathies. In: Hilton-Jones D, Turner MR (eds) Oxford texbook of neuromuscular disorders. Oxford University Press, Oxford, pp 288–301 Vissing J, Orngreen M (2014) Metabolic myopathies. In: Hilton-Jones D, Turner MR (eds) Oxford texbook of neuromuscular disorders. Oxford University Press, Oxford, pp 288–301
go back to reference Vissing J, Galbo H, Haller RG (1996) Paradoxically enhanced glucose production during exercise in humans with blocked glycolysis caused by muscle phosphofructokinase deficiency. Neurology 47:766–771CrossRefPubMed Vissing J, Galbo H, Haller RG (1996) Paradoxically enhanced glucose production during exercise in humans with blocked glycolysis caused by muscle phosphofructokinase deficiency. Neurology 47:766–771CrossRefPubMed
go back to reference Vissing J, Quistorff B, Haller RG (2005) Effect of fuels on exercise capacity in muscle phosphoglycerate mutase deficiency. Arch Neurol 62:1440–1443CrossRefPubMed Vissing J, Quistorff B, Haller RG (2005) Effect of fuels on exercise capacity in muscle phosphoglycerate mutase deficiency. Arch Neurol 62:1440–1443CrossRefPubMed
go back to reference Voet NB, van der Kooi EL, Riphagen II, Lindeman E, van Engelen BG, Geurts AC (2013) Strength training and aerobic exercise training for muscle disease. Cochrane Database Syst Rev 7:CD003907. doi:10.1002/14651858, CD003907.pub4., CD003907PubMed Voet NB, van der Kooi EL, Riphagen II, Lindeman E, van Engelen BG, Geurts AC (2013) Strength training and aerobic exercise training for muscle disease. Cochrane Database Syst Rev 7:CD003907. doi:10.​1002/​14651858, CD003907.pub4., CD003907PubMed
go back to reference Wuyts W, Reyniers E, Ceuterick C, Storm K, De BT, Martin JJ (2005) Myopathy and phosphorylase kinase deficiency caused by a mutation in the PHKA1 gene. Am J Med Genet A 133A:82–84CrossRefPubMed Wuyts W, Reyniers E, Ceuterick C, Storm K, De BT, Martin JJ (2005) Myopathy and phosphorylase kinase deficiency caused by a mutation in the PHKA1 gene. Am J Med Genet A 133A:82–84CrossRefPubMed
Metadata
Title
Exercise in muscle glycogen storage diseases
Authors
Nicolai Preisler
Ronald G Haller
John Vissing
Publication date
01-05-2015
Publisher
Springer Netherlands
Published in
Journal of Inherited Metabolic Disease / Issue 3/2015
Print ISSN: 0141-8955
Electronic ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-014-9771-y

Other articles of this Issue 3/2015

Journal of Inherited Metabolic Disease 3/2015 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.